After Hours Most Active for Mar 13, 2025 : HTZ, NVDA, HOOD, TD, HPE, PRMB, AVGO, AAPL, BAM, SLF, EW, TSLA
Written by Emily J. Thompson, Senior Investment Analyst
Source: NASDAQ.COM
NASDAQ 100 After Hours Performance: The NASDAQ 100 is up by 43.03 points to 19,268.51 with a total after-hours trading volume of over 101 million shares, featuring active stocks like Hertz, NVIDIA, and Robinhood showing positive movements or stability.
Stock Recommendations and Forecasts: Several companies including NVIDIA, Robinhood, and Broadcom have received multiple upward revisions in their earnings forecasts, with current recommendations generally falling within the "buy range" according to Zacks.
Analyst Views on EW
Wall Street analysts forecast EW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EW is 96.52 USD with a low forecast of 84.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
24 Analyst Rating
16 Buy
8 Hold
0 Sell
Moderate Buy
Current: 85.140
Low
84.00
Averages
96.52
High
105.00
Current: 85.140
Low
84.00
Averages
96.52
High
105.00
About EW
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
